Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
2.120
+0.070 (3.41%)
At close: Dec 9, 2025, 4:00 PM EST
2.080
-0.040 (-1.89%)
After-hours: Dec 9, 2025, 7:21 PM EST
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $80.06 million as of December 9, 2025. Its market cap has increased by 148.65% in one year.
Market Cap
80.06M
Enterprise Value
78.06M
1-Year Change
148.65%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $80.06M, an increase of 4,404.00%. That is a compound annual growth rate of 235.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 80.06M | 84.41% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |